Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 3
2007 2
2008 2
2011 1
2012 2
2013 6
2014 2
2015 5
2016 6
2017 4
2018 9
2019 1
2020 8
2021 4
2022 11
2023 16
2024 15
2025 18
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
Zhuang Q, Liao A, He Q, Liu C, Zheng C, Li X, Liu Y, Wang B, Liu S, Zhang Y, Lin R, Chen H, Deng M, Tang Y, He C, Dai W, Tang H, Gong L, Li L, Xu B, Yang C, Zhou B, Su D, Guo Q, Li B, Zhou Y, Wang X, Fei S, Wu H, Wei S, Peng Z, Wang J, Li Y, Wang H, Deng T, Ding S, Li F, Chen M, Xiao Y. Zhuang Q, et al. Among authors: chen h. J Gastroenterol Hepatol. 2024 Apr;39(4):658-666. doi: 10.1111/jgh.16471. Epub 2024 Jan 22. J Gastroenterol Hepatol. 2024. PMID: 38251791 Clinical Trial.
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial.
Song Z, Zhou L, Wang W, Lan C, Tang T, Xie J, Fan H, Wang X, Zuo X, Zhu Y, Liu C, Gu Y, Feng H, Gao X, Zhang Q, Zhang H, Chen J, Geng G, Ma Z; EVEREST-HP Study Group. Song Z, et al. Lancet Infect Dis. 2026 Jan;26(1):101-110. doi: 10.1016/S1473-3099(25)00438-4. Epub 2025 Sep 10. Lancet Infect Dis. 2026. PMID: 40945526 Clinical Trial.
The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.
Tan N, Wu H, Lan C, Liu C, Liao A, Jiao Z, Su D, Zhang X, Zhang Z, Xiao W, Li F, Li X, Xia M, Qiu R, Chen H, Liu Y, Su M, Chen M, Xiao Y. Tan N, et al. Among authors: chen h. Int J Antimicrob Agents. 2024 Nov;64(5):107320. doi: 10.1016/j.ijantimicag.2024.107320. Epub 2024 Sep 16. Int J Antimicrob Agents. 2024. PMID: 39293772 Free article. Clinical Trial.
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Bai T, Xu Z, Zhen Y, Liao A, Wang B, Zhao R, Zhu Y, Dai N, Liu S, Zhao H, Chen X, Huang K, Xu M, Zhou W, Xu B, Ye B, Zou D, Zhang H, Shi R, Zhang J, Ai Y, Fang X, Lin L, Zhang X, Zhang L, Wang J, Jiang Y, Cui J, Zhang M, Ding X, Zhou Z, Yan P, Li X, Jiang B, Liu Y, Ma Y, Yang S, Wang X, Wu Y, Wu J, Chen H, Hou X. Bai T, et al. Among authors: chen h. Drugs. 2025 Aug;85(8):1033-1048. doi: 10.1007/s40265-025-02205-w. Epub 2025 Jun 26. Drugs. 2025. PMID: 40571893 Clinical Trial.
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trial.
Song Z, Wang W, Li P, Zuo X, Zhu Y, Chen Y, Zhang X, Lyu B, Lin R, Du Y, Lan C, Wu H, Chen W, Ye Y, Fan H, Liao A, Chen H, Liu C, Zhang Z, Wang W, Suo Z, Li X, Du Q, Li X, Pan F, Tang J, Xu M, Liu X, Zheng P, Chen H, Du L, Lu J, Feng C, Pan W, Wang H, Zeng Z, Wang J, Lyu S, Liu D, Yang S, Li L, Zhou L. Song Z, et al. Among authors: chen h. Chin Med J (Engl). 2025 Aug 22. doi: 10.1097/CM9.0000000000003780. Online ahead of print. Chin Med J (Engl). 2025. PMID: 40846665
115 results